SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-24-000096
Filing Date
2024-05-30
Accepted
2024-05-30 16:48:30
Documents
21
Period of Report
2024-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20240530.htm   iXBRL 8-K 29577
2 EX-99.1 a2024_prx0530xivonescima.htm EX-99.1 19754
7 a2024_prx0530xivonescima001.jpg GRAPHIC 259233
8 a2024_prx0530xivonescima002.jpg GRAPHIC 259623
9 a2024_prx0530xivonescima003.jpg GRAPHIC 215051
10 a2024_prx0530xivonescima004.jpg GRAPHIC 219155
11 a2024_prx0530xivonescima005.jpg GRAPHIC 200997
12 a2024_prx0530xivonescima006.jpg GRAPHIC 99575
  Complete submission text file 0001599298-24-000096.txt   1939050

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20240530.xsd EX-101.SCH 2161
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20240530_def.xml EX-101.DEF 14787
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20240530_lab.xml EX-101.LAB 26043
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20240530_pre.xml EX-101.PRE 15429
24 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20240530_htm.xml XML 2735
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 241006214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)